PILA PHARMA AB Statistics
PILA PHARMA AB (5KC) Stock Statistics & Valuation Metrics
Total Valuation
PILA PHARMA AB has a market cap or net worth of EUR 6.87M. The enterprise value is EUR 42.98M.
- Market Cap
- EUR 6.87M
- Enterprise Value
- EUR 42.98M
Share Statistics
PILA PHARMA AB has 45,682,120 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 45,682,120
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PILA PHARMA AB’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -53.40%.
- Return on Equity (ROE)
- -1.14
- Return on Assets (ROA)
- -1.04
- Return on Invested Capital (ROIC)
- -53.40%
- Return on Capital Employed (ROCE)
- -0.53
- Revenue Per Employee
- 1.13M
- Profits Per Employee
- -16.86M
- Employee Count
- 1
- Asset Turnover
- 0.07
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of PILA PHARMA AB is -4.12. PILA PHARMA AB’s PEG ratio is 4.77.
- PE Ratio
- -4.12
- PS Ratio
- 277.50
- PB Ratio
- 3.78
- Price to FCF
- -3.68
- Price to Operating Cash Flow
- -2.93
- PEG Ratio
- 4.77
Income Statement
In the last 12 months, PILA PHARMA AB had revenue of 1.13M and earned -16.86M in profits. Earnings per share was -0.49.
- Revenue
- 1.13M
- Gross Profit
- -6.82M
- Operating Income
- -7.89M
- Pretax Income
- -16.86M
- Net Income
- -16.86M
- EBITDA
- -15.92M
- Earnings Per Share (EPS)
- -0.49
Cash Flow
In the last 12 months, operating cash flow was -20.79M and capital expenditures 0, giving a free cash flow of -20.79M billion.
- Operating Cash Flow
- -20.79M
- Free Cash Flow
- -20.79M
- Free Cash Flow per Share
- -0.57
Dividends & Yields
PILA PHARMA AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -27.18%
- Earnings Yield
- -27.50%
Stock Price Statistics
- Beta
- 0.18
- 52-Week Price Change
- -22.28%
- 50-Day Moving Average
- 0.14
- 200-Day Moving Average
- 0.13
- Relative Strength Index (RSI)
- 53.94
- Average Volume (3m)
- ―
Important Dates
PILA PHARMA AB upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Feb 25, 2027
- Ex-Dividend Date
- ―
Financial Position
PILA PHARMA AB as a current ratio of 11.26, with Debt / Equity ratio of 0.00%
- Current Ratio
- 11.26
- Quick Ratio
- 11.26
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.00
- Interest Coverage Ratio
- -36.05
Taxes
In the past 12 months, PILA PHARMA AB has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
PILA PHARMA AB EV to EBITDA ratio is -10.91, with an EV/FCF ratio of -3.52.
- EV to Sales
- 265.69
- EV to EBITDA
- -10.91
- EV to Free Cash Flow
- -3.52
- EV to Operating Cash Flow
- -3.52
Balance Sheet
PILA PHARMA AB has EUR 3.26M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 3.26M billion.
- Cash & Marketable Securities
- EUR 3.26M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 3.26M
- Net Cash Per Share
- EUR 0.07
- Tangible Book Value Per Share
- EUR 0.44
Margins
Gross margin is -2158.59%, with operating margin of -2825.74%, and net profit margin of -6080.90%.
- Gross Margin
- -2158.59%
- Operating Margin
- -2825.74%
- Pretax Margin
- -6080.90%
- Net Profit Margin
- -6080.90%
- EBITDA Margin
- -2435.09%
- EBIT Margin
- -2825.74%
Analyst Forecast
The average price target for PILA PHARMA AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -70.92%
- EPS Growth Forecast
- -27.35%

